PLASMA SPEAKER
    3.
    发明申请
    PLASMA SPEAKER 审中-公开

    公开(公告)号:US20190215616A1

    公开(公告)日:2019-07-11

    申请号:US16304594

    申请日:2017-06-21

    申请人: Paul Gilligan

    发明人: Paul Gilligan

    IPC分类号: H04R23/00 H04R1/30 B03C3/38

    摘要: A speaker (10) comprises an enclosure (8) defining an internal volume (11); and at least one sound generator (7), the sound generator (7) comprising one or more surfaces defining an air-path conduit (15) through which air operably passes in and out of the internal volume. The sound generator (7) further comprises a plurality of electrodes comprising at least one air-exposed electrode (1, 4) and at least one insulated electrode (2, 3). A voltage source (6) is configured to generate an electrical field between the at least one air-exposed electrode (1, 4) and the at least one insulated electrode (2, 3, 70) to operatively generate a plasma proximal (100) to the plurality of electrodes and within the air-path conduit (15).

    Azolo triazines and pyrimidines
    5.
    发明授权
    Azolo triazines and pyrimidines 有权
    偶氮三嗪和嘧啶

    公开(公告)号:US06358950B1

    公开(公告)日:2002-03-19

    申请号:US09696759

    申请日:2000-10-26

    IPC分类号: C07D48704

    CPC分类号: C07D487/04

    摘要: Corticotropin releasing factor (CRF) antagonists of formula I or II: and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.

    摘要翻译: 式I或II的促肾上腺皮质激素释放因子(CRF)拮抗剂及其用于治疗焦虑,抑郁和其他精神疾病,神经障碍以及治疗与精神病理学障碍和应激相关的免疫学,心血管或心脏相关疾病和结肠超敏反应的用途 。

    Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
    8.
    发明申请
    Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist 有权
    促肾上腺皮质激素释放因子受体拮抗剂的盐及其结晶形式

    公开(公告)号:US20050113375A1

    公开(公告)日:2005-05-26

    申请号:US10985115

    申请日:2004-11-10

    IPC分类号: C07D487/04 A61K31/53

    CPC分类号: C07D487/04

    摘要: The present invention provides 4-(bis(2-methoxyethyl)amino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-[1,5-α]-pyrazolo-1,3,5-triazine benzenesulfonate salt and a crystalline polymorph thereof. Further provided are pharmaceutical compositions containing the salt and methods of treating CRF-related disorders using said salt.

    摘要翻译: 本发明提供4-(双(2-甲氧基乙基)氨基)-2,7-二甲基-8-(2-甲基-4-甲氧基苯基) - [1,5-a] - 吡唑并[ 三嗪苯磺酸盐及其结晶多晶型物。 还提供含有盐的药物组合物和使用所述盐治疗CRF相关病症的方法。

    Plasma speaker
    10.
    发明授权

    公开(公告)号:US10567887B2

    公开(公告)日:2020-02-18

    申请号:US16304594

    申请日:2017-06-21

    申请人: Paul Gilligan

    发明人: Paul Gilligan

    IPC分类号: H04R23/00 H04R1/30 B03C3/38

    摘要: A speaker (10) comprises an enclosure (8) defining an internal volume (11); and at least one sound generator (7), the sound generator (7) comprising one or more surfaces defining an air-path conduit (15) through which air operably passes in and out of the internal volume. The sound generator (7) further comprises a plurality of electrodes comprising at least one air-exposed electrode (1, 4) and at least one insulated electrode (2, 3). A voltage source (6) is configured to generate an electrical field between the at least one air-exposed electrode (1, 4) and the at least one insulated electrode (2, 3, 70) to operatively generate a plasma proximal (100) to the plurality of electrodes and within the air-path conduit (15).